Loading
Cero Therapeutics Holdings, Inc. Stock: price and insider trades · United States
US·Mcap US$451.1k
Cero Therapeutics Holdings, Inc.: what insiders have been doing
Every trade that managers of Cero Therapeutics Holdings, Inc. disclose to SEC (Form 4) is tracked on this page. Cero Therapeutics Holdings, Inc. has had no insider filing for more than a year; the last one goes back to 4 April 2025.
Since 2021, the database holds no purchases and 4 sales by insiders of the company.
Other companies in the same market with recent insider buying flagged by our signals: GameStop Corp. and Heico Corp. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
21
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€589,415
4 ops. · all time
Who traded when
BuySaleYK Bioventures Opportunities GP I, LLC2 sales
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
US$0.01
Analyst consensus
Income statement
EBITDA-US$18.2M
Net income-US$95.5M0.0% margin
Valuation
PER (trailing)0.0x
Beta0.16
Balance sheet & cash
Market capUS$451.1k
Total debtUS$699.1k
Free Cash Flow-US$16.1M
Profitability & ownership
ROA-241.1%
% insiders4.1%
% institutions0.1%
Last declaration on 4 April 2025
Declarations21 total
294,460 shares100.0% of flowCommon StockSEC:0001213900-25-029111:0
1,343,801 shares@ US$0.0818.9% of flowCommon StockSEC:0001415889-24-029371:0
1,236,874 shares@ US$0.1226.0% of flowCommon StockSEC:0001415889-24-028899:0
532,486 shares@ US$0.1043100.0% of flowCommon Stock, $0.0001 par value per shareSEC:0001753926-24-001975:0
3,250,000 shares@ US$0.1055.1% of flowCommon StockSEC:0001415889-24-026908:0
19,358,578 sharesCommon StockSEC:0001213900-24-084829:0
5,312,983 sharesCommon StockSEC:0001213900-24-084830:0
965,997 sharesCommon StockSEC:0001213900-24-084831:0
100,527 sharesCommon StockSEC:0001213900-24-021525:0
100,527 sharesCommon StockSEC:0001213900-24-015874:0
5,828 sharesClass A Common StockSEC:0001213900-24-015032:0
5,828 sharesCommon StockSEC:0001213900-24-015027:0
10,002 sharesClass A Common StockSEC:0001213900-24-015030:0
43,300 sharesClass A Common StockSEC:0001213900-24-015029:0
125,000 sharesCommon StockSEC:0001213900-24-015024:0
1,125,000 sharesCommon StockSEC:0001213900-24-015028:0
1,125,000 sharesCommon StockSEC:0001213900-24-015026:0
5,828 sharesClass A Common StockSEC:0001213900-24-015034:0
36,733 shares@ US$10.00100.0% of flowClass A common stockSEC:0000899243-21-039941:0
10,000 sharesClass A common stockSEC:0000899243-21-039936:0
36,733 shares@ US$10.00100.0% of flowClass A common stockSEC:0000899243-21-039943:0
21 of 21 declarations
About Cero Therapeutics Holdings, Inc.
CERO Therapeutics Holdings, Inc. is a company focused on developing innovative therapies to treat serious diseases. It is listed on NASDAQ under the ticker CERO.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations
